agilon health (NYSE:AGL) Raised to “Neutral” at Citigroup

Citigroup upgraded shares of agilon health (NYSE:AGL) from a sell rating to a neutral rating in a report released on Friday morning, Marketbeat.com reports. Citigroup currently has $2.25 target price on the stock, up from their previous target price of $1.75.

A number of other brokerages also recently commented on AGL. Evercore ISI lowered their price objective on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 8th. Sanford C. Bernstein assumed coverage on shares of agilon health in a report on Wednesday, December 11th. They set a “market perform” rating and a $2.50 price target on the stock. TD Cowen cut their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd. Finally, Barclays dropped their target price on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday, November 11th. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $3.98.

agilon health Price Performance

Shares of NYSE:AGL opened at $2.42 on Friday. The company has a market cap of $997.08 million, a P/E ratio of -2.57 and a beta of 0.53. The company’s fifty day moving average is $2.07 and its two-hundred day moving average is $3.73. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 12-month low of $1.50 and a 12-month high of $8.20.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period in the previous year, the firm posted ($0.06) earnings per share. Equities analysts expect that agilon health will post -0.52 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Diana Mckenzie purchased 12,500 shares of the business’s stock in a transaction on Monday, November 25th. The stock was purchased at an average price of $2.28 per share, with a total value of $28,500.00. Following the acquisition, the director now directly owns 51,319 shares in the company, valued at approximately $117,007.32. The trade was a 32.20 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, Director John William Wulf acquired 45,000 shares of agilon health stock in a transaction on Thursday, December 5th. The stock was purchased at an average price of $2.18 per share, with a total value of $98,100.00. Following the transaction, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 90,000 shares of company stock valued at $198,100. 3.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Point72 Asia Singapore Pte. Ltd. acquired a new position in agilon health in the third quarter valued at about $28,000. City State Bank bought a new stake in shares of agilon health during the third quarter valued at approximately $52,000. Aigen Investment Management LP acquired a new stake in shares of agilon health in the third quarter valued at approximately $79,000. SG Americas Securities LLC bought a new position in agilon health in the 3rd quarter worth approximately $92,000. Finally, Point72 DIFC Ltd acquired a new position in agilon health during the 3rd quarter worth $99,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.